Staburo is top company 2024

Staburo is top company 2024

Staburo is one of the top companies 2024

We are proud to announce that the employer rating platform kununu recognizes Staburo GmbH as top company 2024.

The award is based on the independent assessments of our employees on the platform. This makes Staburo one of the companies with the best working environment in Germany.

This result is in line with our company philosophy. We are committed to the highest ethical standards, social responsibility, and integrity. We have a common mindset which reflects current social topics including compliance, data privacy, environmental sustainability, protection of human rights, gender diversity, fairness, and ethical behaviour.

Staburo’s Managing Directors – Hannes Buchner, Josef Höfler and Roland Stieger – emphasize that a great work environment is key in our company. The character of our company culture and spirit is based on our core values: permanence, open-minded, service and support mindset, solidarity and fun, curiosity and willingness to learn, reliability and commitment. Our daily communication and interactions within the team, towards clients and partners are built on these fundamental principles.

We are delighted about this award with 4.7 out of 5 stars and would like to thank all our employees for their continuous great work, trust and feedback.

Click here for our kununu company profile: https://www.kununu.com/de/staburo1

We look forward to continuing to deliver excellent data science to improve and save lives.

Happy new year 2024 to everyone!

Data analysis, clinical biostatistics and more.

Staburo Christmas Party 2023 & Merry Christmas

Staburo Christmas Party 2023 & Merry Christmas

Staburo Christmas Party 2023 & Merry Christmas everyone

A couple of days ago we came together in Munich for our annual Christmas party. All colleagues from Munich, the surrounding area or even from other cities met at Nockherberg for our first Staburo ice curling company event. Our colleagues played across teams enthusiastic and fully committed on four lanes, drank mulled wine, and enjoyed the winter wonderland.

Followed by this fun and snowy part of ice curling we all moved on together to our dinner location – Falke 23 in Munich. Here we spent a wonderful evening with delicious food, good drinks, an award ceremony, as well as many conversations and laughts. We are delighted with this successful evening and that so many of our colleagues were able to attend!

Once again, we would like to thank all our employees for their great commitment and our customers for their trust and great cooperation. We are already looking forward to the next year and what it has to offer for all of us.

We wish you a merry Christmas, relaxing holidays, and a happy new year 2024!

Data analysis, clinical biostatistics and more.

Staburo presents @ PSI Biomarkers SIG meeting

Staburo presents @ PSI Biomarkers SIG meeting

Staburo presents @ PSI Biomarkers SIG meeting

A couple of weeks ago, Staburo’s Head of Biostatistics and Managing Director, Hannes Buchner, took the opportunity to share insights from the research project titled “Deriving Interpretable Thresholds for Variable Importance in Random Forests by Permutation” at the monthly meeting of the PSI Biomarkers European Special Interest Group (SIG). 

PSI, a non-profit community, is committed to advancing and promoting the use of statistics within the healthcare industry to ultimately benefit patients. Connecting over a thousand members and fostering communication among more than 2000 individuals in its online communities, PSI offers a platform where professionals can exchange ideas and network. Throughout their careers, members are supported with resources such as scientific meetings, online training, networking events, and the journal Pharmaceutical Statistics. 

The PSI Biomarkers SIG, comprising 44 members from industry and academia, aims to develop advanced analytical methods for biomarker analysis in clinical development. The group also seeks to enhance interaction with various disciplines and establish connections with other SIGs. 

Hannes’ presentation detailed a collaborative effort between Staburo employees Laura Schlieker, Maria Blanco and Tim Müller, Armin Ott from Roche Diagnostics and Roman Hornung from the Institute for Medical Information Processing, Biometry and Epidemiology, University of Munich. The project explores the Random Forest (RF) method and its application in high-dimensional data analysis, biomarkers research, and personalized medicine. The research group has been focused on identifying all relevant covariables in RF predictions. During the presentation, Hannes introduced the Boruta algorithm, outlined the improvements proposed by the research group, and compared the performance of both methods using real and simulated data sets. 

Staburo’s participation in the PSI Biomarkers SIG meeting was an opportunity to engage with its members – thanks for the great organisation!

Data analysis, clinical biostatistics and more.

Staburo @ APF meeting 2023

Staburo @ APF meeting 2023

Staburo @ APF meeting in Darmstadt

A few days ago – we from Staburo GmbH, Hannes Buchner, Stephan Bischofberger, Gabriele Bleckert, Sarah Musiol, Jiali Lin  – joined the annual APF meeting in November: It all started with a fantastic get-together on Thursday evening at the Grohe Brauhaus in Darmstadt. We had a great evening and lots of networking opportunities in this location with joining so many participants from our industry.

The next day started with our morning session including 4 great and interesting presentations about biomarkers and decision making of which one was by our Managing Director, Hannes Buchner. We gained many insights into biomarker analyses and tools at different companies from sponsors to CROs.

After a well-deserved lunch break we kicked-off our afternoon session which was about estimands in early phase trials in oncology with 2 presentations. During those sessions and discussions the topic how to use estimands in early phase was challenged and in the end still recommended to use at least an ‘estimand thinking’ approach, since it is a must in late phase trials and since it helps understanding the actual objectives of the whole development program.

Many thanks to Merck for organizing and hosting this year’s meeting and also to everyone who joined and contributed to this interesting and insightful event.

We are already looking forward to the next meetings!

Data analysis, clinical biostatistics and more.

Staburo @ European Statistical Forum

Staburo @ European Statistical Forum

Staburo @ European Statistical Forum in Munich

On Tuesday, 14th November 2023, the Staburo team comprising Hannes Buchner, Laura Schlieker and Sarah Mwiberi Juckel attended the 14th European Statistical Forum held in Munich, Germany. The conference was organised by life science academy and attracted participants from both academia and industry all over Europe.

The theme of the conference was statistical methodology in precision medicine and the role of artificial intelligence. A wide range of topics all centered around precision medicine were presented including creation of fairer ML algorithms, quantification of uncertainty on ML systems, training a learner algorithm, biomarker threshold optimisation, application of polygenic scores in clinical trials as well as AI/ML and omics methods. The keynote speaker was Prof. Werner Brannath from the University of Bremen. He gave a presentation on the population-wise error rate (PWER), a novel type I error rate which has applications in clinical trials with multiple populations where there is a chance for multiple type I errors.

The conference concluded with an interactive Q & A session, in which speakers and attendees discussed the current and future roles of statistics, precision medicine and artificial intelligence in the pharmaceutical industry.

The conference also allowed for networking and intense discussions during breaks. We look forward to sharing our insights with our colleagues at Staburo.

Data analysis, clinical biostatistics and more.

Staburo @ BIO-Europe 2023

Staburo @ BIO-Europe 2023

Staburo @ BIO-Europe 2023 in Munich

Staburo’s Managing Director Roland Stieger joined the BIO-Europe two weeks ago and enjoyed the great networking opportunities of this partnering conference with over 5000 delegates!

In addition to several one-on-one meetings, in which Roland discussed data science challenges of potential partners, we were very happy to have our brand and company information shared at the Bavarian booth, thanks to Bio-M.

Roland also attended the well-organized official BIO-Europe evening receptions, in the famous Residenz and at the Nockherberg where it was very nice to catch up with known and introduced colleagues, all from our industry. Thanks to EBD for this great conference!

Data analysis, clinical biostatistics and more.